Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group - Summary - MDSpire

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • By

  • Vanessa Hubertus

  • Lennart Viezens

  • Martin Stangenberg

  • Anton M. Früh

  • Hanno S. Meyer

  • Raimunde Liang

  • Andreas Kramer

  • Christoph Orban

  • Johannes Kerschbaumer

  • Beate Kunze

  • Stefano Telera

  • Hannah Miller

  • Christian J. Entenmann

  • Emily J. von Bronewski

  • Charlotte Buhre

  • Leon-Gordian Leonhardt

  • Wolfgang Willenbacher

  • Irma Kvitsaridze

  • Dominik Laue

  • Matthias Pumberger

  • Theresa Keller

  • Güliz Acker

  • Jan Krönke

  • Igor-Wolfgang Blau

  • Ulrich Keller

  • Florian Ringel

  • Claudius Thomé

  • Bernhard Meyer

  • Peter Vajkoczy

  • Marc Dreimann

  • Julia Sophie Onken

  • June 13, 2025

  • 0 min

Share

Objective:

To investigate the surgical management and practice variations in the treatment of Multiple Myeloma patients with symptomatic vertebral column lesions, focusing on indications, timing, and outcomes.

Key Findings:
  • 80% of MM patients experience bone-related complications, with 50% from vertebral lesions, highlighting the clinical burden.
  • Surgical interventions are often avoided due to risks of infections and compromised bone integrity, indicating a need for better risk assessment.
  • Cement augmentation is effective for pain relief but does not restore spinal stability, underscoring the limitations of current non-surgical options.
  • Standardized surgical guidelines for MM-related vertebral lesions are lacking, which may contribute to practice variations.
Interpretation:

The study highlights significant practice variations in the surgical management of vertebral lesions in MM patients, indicating a critical need for standardized treatment protocols to improve patient outcomes.

Limitations:
  • Retrospective nature may introduce bias, potentially affecting the reliability of the findings.
  • Lack of standardized treatment guidelines limits comparability and generalizability of the results.
  • Data collected from a specific registry may not represent all MM patients, which could skew the understanding of practice variations.
Conclusion:

There is a critical need for evidence-based surgical guidelines for managing vertebral lesions in Multiple Myeloma patients to improve outcomes and reduce practice variations, ultimately enhancing patient care.

Original Source(s)

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • by Vanessa Hubertus, Lennart Viezens, Martin Stangenberg, Anton M. Früh, Hanno S. Meyer, Raimunde Liang, Andreas Kramer, Christoph Orban, Johannes Kerschbaumer, Beate Kunze, Stefano Telera, Hannah Miller, Christian J. Entenmann, Emily J. von Bronewski, Charlotte Buhre, Leon-Gordian Leonhardt, Wolfgang Willenbacher, Irma Kvitsaridze, Dominik Laue, Matthias Pumberger, Theresa Keller, Güliz Acker, Jan Krönke, Igor-Wolfgang Blau, Ulrich Keller, Florian Ringel, Claudius Thomé, Bernhard Meyer, Peter Vajkoczy, Marc Dreimann, Julia Sophie Onken

  • June 13, 2025

Related Content

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research